🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our FlexOMx Lab™ offers a suite of new, flexible lab services to continue our support of biopharma partners and their research and discovery needs. Check out the lab and its capabilities and offerings in our latest blog: spkl.io/6013f2QaZ

Foundation Medicine is excited to join patients, advocates, healthcare providers and biopharmaceutical partners at #ASCO25. With 15+ new pieces of research being presented, we look forward to joining the oncology community in Chicago. Learn more: spkl.io/6019fNy4W

Announcing our new, expanded immunohistochemistry (IHC) test offerings to include MET IHC testing as an add-on to Foundation Medicine’s comprehensive genomic profiling (CGP) test orders for patients with non-squamous non-small cell lung cancer: spkl.io/6019fNZQz

Connect with Foundation Medicine in Chicago! Stop by Booth 27021 to learn more about our high-quality tests and work in precision cancer care: spkl.io/6012ffroj #ASCO25

Two pieces of research at #ASCO25 feature new data on the detection of clonal hematopoiesis in #PancreaticCancer and #OvarianCancer using liquid biopsies. Discover more & connect with our team – Booth 27021: spkl.io/6010ffdYC

We’re in Chicago for #ASCO25 – come visit us at booth 27021 to learn more about Foundation Medicine. Schedule a meeting with us today: spkl.io/6014ffdmC #MissNotOne

Learn more about the latest in non-small cell #LungCancer (NSCLC) with two new presentations at #ASCO25. Connect with us at booth 27021: spkl.io/6015ffeRJ

New study at #ASCO25 analyzes the genomic landscape of NPM1 genomic alterations in acute myeloid leukemia. Find out more and meet with our team – Booth 27021: spkl.io/6018fferC

New research being presented at #ASCO25 showcases new innovations in #BreastCancer treatment and care. Hear some quick highlights from Dr. Julia Quintanilha, Senior Scientist at Foundation Medicine. Learn more: spkl.io/6016ffeTQ

Honored to have joined the oncology community and to have been part of #ASCO25. Our team had so many great interactions and conversations last week in Chicago. #WeAreFMI #MissNotOne

This year, Foundation Medicine celebrates our 15th anniversary. Look back at the milestones we’ve achieved in a new blog from our CEO Dan Malarek: foundationmedicine.com/blog/15-year-a…

Utilizing Foundation Medicine’s tissue-free treatment response monitoring assay, new #research demonstrated the clinical value of treatment response monitoring by ctDNA in real-world patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

We’re still thinking back about our time at #ASCO25! The meeting always provides some time to reflect upon and learn more about the latest advancements in oncology. We asked some of our team members what gives them hope about the future of cancer care. Hear what they had to say.

#NewResearch in npj Journals precision oncology: “Tissue-based genomic profiling of 300,000 tumors highlights the detection of variants with low allele fraction.” Explore the publication here: spkl.io/6015ABS9H

July is UV Awareness Month, a time dedicated to share resources and education around the dangers of ultraviolet (UV) radiation. UV exposure involves risks, including sunburns and skin cancer. Read our post for some key facts.

#NewResearch in The Oncologist: “Clinical utility of companion diagnostic biomarker results below the limit of detection in comprehensive genomic profiling of patients with advanced non-small cell lung cancer.” Click here for the full publication: spkl.io/6011AE45U